 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | TTRNA-DCs / University of Florida
Trial completion date, Trial primary completion date: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Nov 19, 2024
P1, N=21, Active, not recruiting, Sponsor: University of Florida
Trial completion date: Jun 2025 --> Dec 2025 | Trial primary completion date: Dec 2024 --> Jun 2025
- | TTRNA-DCs / University of Florida
Trial initiation date, Checkpoint inhibition, Checkpoint block: MATCHPOINT: Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma (clinicaltrials.gov) - Oct 15, 2024
P1, N=12, Not yet recruiting, Sponsor: University of Florida
Trial completion date: Jun 2025 --> Dec 2025 | Trial primary completion date: Dec 2024 --> Jun 2025 Initiation date: Sep 2024 --> Dec 2024
- | TTRNA-DCs / University of Florida
New P1 trial, Checkpoint inhibition, Checkpoint block: MATCHPOINT: Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma (clinicaltrials.gov) - Jul 23, 2024
P1, N=12, Not yet recruiting, Sponsor: University of Florida
- | TTRNA-DCs / University of Florida
Trial completion date, Trial primary completion date: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Dec 31, 2023
P1, N=21, Active, not recruiting, Sponsor: University of Florida
- | TTRNA-DCs / University of Florida
Enrollment closed: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Nov 18, 2023
P1, N=21, Active, not recruiting, Sponsor: University of Florida
Initiation date: Sep 2024 --> Dec 2024 Recruiting --> Active, not recruiting
- | TTRNA-DCs / University of Florida
Trial completion date, Trial primary completion date: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Feb 3, 2023
P1, N=21, Recruiting, Sponsor: University of Florida
Recruiting --> Active, not recruiting Trial completion date: Jun 2024 --> Jun 2025 | Trial primary completion date: Dec 2023 --> Dec 2024
- | TTRNA-DCs / University of Florida
Trial primary completion date: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - May 2, 2022
P1, N=21, Recruiting, Sponsor: University of Florida
Trial completion date: Jun 2024 --> Jun 2025 | Trial primary completion date: Dec 2023 --> Dec 2024 Trial primary completion date: Dec 2022 --> Dec 2023
- | TTRNA-DCs / University of Florida
Trial completion date, Trial primary completion date: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Sep 14, 2020
P1, N=21, Recruiting, Sponsor: University of Florida
Trial primary completion date: Dec 2022 --> Dec 2023 Trial completion date: Jun 2022 --> Jun 2024 | Trial primary completion date: Dec 2020 --> Dec 2022
- | TTRNA-DCs / University of Florida
New P1 trial: BRAVO: Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (clinicaltrials.gov) - Jan 10, 2018
P1, N=21, Not yet recruiting, Sponsor: University of Florida